IGC Pharma (IGC) EBITDA Margin Growth (5y) (2015 - 2025)
IGC Pharma (IGC) EBITDA Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | IGC Pharma | 29.35 Mn | 29.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -17,700.00 |
| Jun 30, 2025 | -25,014.00 |
| Mar 31, 2025 | 799,596.00 |
| Dec 31, 2024 | -43,789.00 |
| Sep 30, 2024 | -35,645.00 |
| Jun 30, 2024 | -79,265.00 |
| Mar 31, 2024 | -62,548.00 |
| Dec 31, 2023 | -134,681.00 |
| Sep 30, 2023 | -75,059.00 |
| Jun 30, 2023 | -35,083.00 |
| Mar 31, 2023 | -237,061.00 |
| Dec 31, 2022 | -62,407.00 |
| Sep 30, 2022 | -111,977.00 |
| Jun 30, 2022 | -57,298.00 |
| Mar 31, 2022 | -453,833.00 |
| Dec 31, 2021 | -152,501.00 |
| Sep 30, 2021 | -742,535.00 |
| Jun 30, 2021 | -273,884.00 |
| Mar 31, 2021 | -331,656.00 |
| Dec 31, 2020 | -211,914.00 |